Your patent is granted. Now what?

The four common routes are licensing for royalties, an outright sale, building a product or company on the patent, and strategic partnerships or joint ventures. Most patents earn nothing — not because they lack value, but because their owners never deliberately pursue one of these paths. Which of the four fits your patent best is usually a quicker read than people expect — it's the kind of question we answer every day.

Selling gives you a clean, immediate payout and transfers all execution risk to the buyer. Licensing keeps ownership with you and can produce recurring royalty income, but requires negotiation, monitoring, and patience. The right answer depends on your capital, how involved you want to be, and how broad the market is. We help owners run that exact comparison against their own patent — the answer is usually hiding in the numbers.

A patent's value comes from the commercial opportunity it controls, not the document itself. Value depends on the size of the market it touches, the strength and breadth of its claims, remaining patent life, evidence of demand or infringement, and how easily the invention can be brought to market. Two patents that look similar on paper can be worth wildly different amounts — and if you're wondering where yours lands, that's precisely the question our commercialization score was built to answer.

Yes — that's exactly what licensing is for. Companies already manufacturing and selling in your space pay you royalties for the right to use your invention. You never build a factory, hire a sales team, or ship a unit. The part most owners haven't done before is finding the right licensee — and that's something we can help with directly.

Start with companies already operating in the patent's field: look at who cites your patent, who holds adjacent patents, and whose products overlap your claims. A targeted, well-researched approach to the right business-development or licensing contact outperforms mass outreach every time. Building that list for a specific patent is something we do regularly — it's usually shorter, and more surprising, than owners imagine.

Commercially valuable patents sit on a real market, solve a problem buyers already pay to solve, have claims broad enough to matter but strong enough to hold up, and are hard to design around. Remaining life, detectability of infringement, and industry momentum all add to value. This is exactly what our Beyond the Patent Commercialization Score tries to capture — and if you want to see how your patent stacks up on each factor, we're always glad to talk it through.

Licensing or partnering is usually the answer. Companies with existing manufacturing, distribution, and customers can bring the invention to market while you earn royalties or a stake. A granted patent is often exactly the asset that makes such a partnership possible — it gives the partner something defensible to invest behind. If that sounds like your situation, the right partner may be closer than you think — worth a conversation.

Audit the portfolio for patents that no longer serve the core business but cover markets others operate in. Those assets can be licensed for royalty streams, sold to operating companies, or bundled into spin-outs and joint ventures — instead of quietly consuming maintenance fees year after year. A portfolio audit usually turns up more value than companies expect — a natural place to start a conversation with us.

It's a progression, not a choice between two firms. Beyond the Patent is the starting point — the day your patent is granted, it helps you understand the commercialization paths, get a professional patent score, and decide what's next. Broadview Holdings is the next stage: when you're an established organization ready to execute, its team handles licensing strategy, patent sales, product development, and IP transactions. Not sure which stage you're in? Reach out — we'll point you the right direction either way.

It varies by path. An outright sale can close in months when a motivated buyer exists; licensing deals often take six months to two years of outreach and negotiation; building a product or company is the longest route, usually measured in years. The owners who move fastest are the ones who pick a path early and pursue it deliberately. Where your patent's timeline realistically sits is something a quick read usually makes clear — feel free to ask.

Royalty rates depend on the industry, the strength of the patent, and how much of the product's value the invention represents. Many industries cluster in the low single digits of sales, while software and pharmaceuticals can run higher. The rate matters less than the volume it applies to — a small percentage of a large market beats a large percentage of nothing. What your specific patent could command becomes visible in a short analysis — that's part of what our score covers.

Not necessarily. A granted patent, clear claims, and a compelling market story are often enough to open licensing conversations. That said, anything that reduces a company's perceived risk — a prototype, test data, or proof of demand — makes the deal easier to close and the terms better. Whether yours needs one is exactly the kind of judgment call we help owners make before they spend the money.

An exclusive license gives one company the sole right to use your invention — usually in exchange for higher royalties or upfront payments. A non-exclusive license lets you license the same patent to multiple companies at once, spreading your bets across a market. The right structure depends on the industry and how much one partner is willing to commit — a strategy question we're glad to think through with you.

The buyers are operating companies that want to protect or expand a product line, investment firms that aggregate IP, and occasionally competitors who would rather own your patent than design around it. The strongest buyers are almost always companies already active in the market your patent covers — and identifying which of them fits your patent, and how to approach them, is where a conversation with us usually starts.

Yes — pending applications can be licensed or sold, and some companies prefer getting in early. But a granted patent is a stronger asset: its claims are examined and defined, which removes a major uncertainty for the buyer or licensee. Many deals are discussed during pendency and close at grant — and if yours is still pending, there are smart moves to make right now that we're happy to walk through.

In most cases, nothing — which is the problem. A patent doesn't generate value on its own; it gives you the right to stop others, and that right only becomes revenue when you license it, sell it, build on it, or partner around it. Meanwhile maintenance fees come due, and the patent's remaining life — a big part of its value — ticks down every year. The good news: changing that usually starts with one conversation about what's actually possible for your patent.

A short, clear summary of what the invention does and the problem it solves; the patent number and status; a picture of the market it touches; and a specific reason each company you contact would benefit. Companies respond to relevance — a tailored approach to five right-fit companies outperforms a generic blast to five hundred. And if you'd rather have that package pressure-tested before it goes out, that's exactly the kind of help we give.

It's our professional assessment of a granted patent's commercial potential across the factors that drive licensing, sale, build, and partner outcomes — market size, claim strength, remaining life, detectability, and industry momentum. The score is our independent editorial opinion, not a valuation or legal opinion. Email ad@broadview-holdings.com for a quote.

For the contract itself, yes — a licensing or purchase agreement should always be handled by a qualified attorney. Where owners get stuck is everything before the contract: choosing a path, valuing the opportunity, and finding the right companies. That strategic groundwork is exactly what Beyond the Patent is built for — start there, and the legal side becomes a much simpler conversation.